talazoparib,enzalutamide
pfizer,astellas
['prostate', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'talapro2', 'enzalu', 'enzalutamide']
#talapro2 #prostatecancer #gu23 presents the data of first line #mcrpc of #parp inhibitor &amp; enzalutamide clear benefit in progression free survival w/expected added toxicity breakdown here by known mutation status 
Clinical researcher focused on #ProstateCancer, early recurrence (#BCR)  & #immunotherapy. Views are my own & do not represent the National Cancer Institute